Syntax Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
Syntax Advisors's MRK Position: Q3 2023 in Review
Syntax Advisors increased its Merck (MRK) stake by 2.6% in Q3 2023, buying an estimated $5.71K and bringing the position to 2,128 shares worth $219K. The position accounts for 0.19% of the portfolio, ranked #156.
Syntax Advisors first reported a position in MRK in Q4 2021 and has held it in 8 quarters since. The position peaked at $274K in Q4 2021. 3,213 funds tracked by Wall St. Rank hold MRK as of Q3 2023.
- Syntax Advisors held 2,128 shares of Merck worth $219K as of Q3 2023.
- Syntax Advisors bought 53 Merck shares in Q3 2023, an estimated $5.71K.
- Merck made up 0.19% of Syntax Advisors's portfolio in Q3 2023, its #156 holding.
- Syntax Advisors first reported a position in Merck in Q4 2021 and has held it in 8 quarters since.
- Syntax Advisors's Merck position peaked at $274K in Q4 2021.
- 3,213 funds tracked by Wall St. Rank held Merck as of Q3 2023.
Based on Syntax Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.